Objectives: Flow cytometry (FC) has become a useful support for cytomorphologic evaluation (CM) of fine-needle aspirates (FNA) and serous cavity effusions (SCE) in cases of suspected non-Hodgkin lymphoma (NHL). FC results may be hampered by the scarce viability and low cellularity of the specimens. Study Design: We developed a single-tube FC assay (STA) that included 10 antibodies cocktailed in 8-color labeling, a cell viability dye, and a logical gating strategy to detect NHL in hypocellular samples. The results were correlated with CM and confirmed by histologic or molecular data when available. Results: Using the STA, we detected B-type NHL in 31 out of 103 hypocellular samples (81 FNA and 22 SCE). Of these, 8 were not confirmed by CM and 2 were considered to be only suspicious. The FC-negative samples had a final diagnosis of benign/reactive process (42/72), carcinoma (27/72), or Hodgkin lymphoma (3/72). Conclusions: The STA approach allowed obtainment of maximum immunophenotyping data in specimens containing a low number of cells and a large amount of debris. The information obtained by STA can help cytomorphologists not only to recognize but also to exclude malignant lymphomas.

Keywords:
Multicolor flow cytometry, Paucicellular samples, Non-Hodgkin lymphomas
1.
Zeppa P, Marino G, Troncone G, Fulciniti F, De Renzo A, Picardi M, Benincasa G, Rotoli B, Vetrani A, Palombini L: Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions. Cancer 2004;102:55-65.
2.
Barrena S, Almeida J, Del Carmen García-Macias M, López A, Rasillo A, Sayagués JM, Rivas RA, Gutiérrez ML, Ciudad J, Flores T, Balanzategui A, Caballero MD, Orfao A: Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology 2011;58:906-918.
3.
Savage EC, Vanderheyden AD, Bell AM, Syrbu SI, Jensen CS: Independent diagnostic accuracy of flow cytometry obtained from fine-needle aspirates: a 10-year experience with 451 cases. Am J Clin Pathol 2011;135:304-309.
4.
Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, Palestro G, Papotti M, Stacchini A: Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: a series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol 2010;18:311-322.
5.
Stacchini A, Carucci P, Pacchioni D, Accinelli G, Demurtas A, Aliberti S, Bosco M, Bruno M, Balbo Mussetto A, Rizzetto M, Bussolati G, De Angelis C: Diagnosis of deep-seated lymphomas by endoscopic ultrasound-guided fine needle aspiration combined with flow cytometry. Cytopathology 2012;23:50-56.
6.
Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González-Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish Group for the Study of CNS Disease in NHL: Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol 2009;27:1462-1469.
7.
Missotten T, Tielemans D, Bromberg JE, van Hagen PM, van Lochem EG, van Dongen JJ, Baarsma GS, Langerak AW: Multicolor flow cytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma. Ophthalmology 2013;120:991-996.
8.
Iqbal J, Liu T, Mapow B, Swami VK, Hou JS: Importance of flow cytometric analysis of serous effusions in the diagnosis of hematopoietic neoplasms in patients with prior hematopoietic malignancies. Anal Quant Cytol Histol 2010;32:161-165.
9.
Cesana C, Klersy C, Scarpati B, Brando B, Volpato E, Bertani G, Faleri M, Nosari A, Cantoni S, Ferri U, Scampini L, Barba C, Lando G, Morra E, Cairoli R: Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids. Leuk Res 2010;34:1027-1034.
10.
Shen H, Tang Y, Xu X, Wang L, Wang Q, Xu W, Song H, Zhao Z, Wang J: Rapid detection of neoplastic cells in serous cavity effusions in children with flow cytometry immunophenotyping. Leuk Lymphoma 2012;53:1509-1514.
11.
Stacchini A, Demurtas A, Aliberti S: Immunophenotyping of paucicellular samples. Curr Protoc Cytom 2014;68:9.46.1-9.46.14.
12.
Zembruski NC, Stache V, Haefeli WE, Weiss J: 7-Aminoactinomycin D for apoptosis staining in flow cytometry. Anal Biochem 2012;429:79-81.
13.
Craig FE, Foon KA: Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941-3967.
14.
Stacchini A, Aliberti S, Demurtas A, Benevolo G, Godio L: Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin's lymphomas. Cytometry B Clin Cytom 2012;82:139-144.
15.
van Dongen JJ, et al; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708): EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012;26:1922-1925.
16.
Preijers FW, Huys E, Moshaver B: OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples. Cytometry A 2012;81:453-455.
17.
Rajab A, Porwit A: Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube. Cytometry B Clin Cytom 2015;88:253-260.
18.
Rajab A, Boerner S, da Cunha Santos G, Geddie W, Ko H, Porwit A: Ten-color 14 antibody flow cytometry panel for immunophenotyping of paucicellular cytologic specimens. Cytometry B Clin Cytom 2013;84:419.
19.
Schwock J, Geddie WR: Diagnosis of B-cell non-Hodgkin lymphomas with small-/intermediate-sized cells in cytopathology. Patholog Res Int 2012;2012:164934.
20.
Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D: Pleural effusions in hematologic malignancies. Chest 2004;125:1546-1555.
21.
Pillai V, Cibas ES, Dorfman DM: A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Am J Clin Pathol 2013;139:672-678.
22.
Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, Veltri A, Maletta F, Molinaro L, Novero D: Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology 2014;25:231-240.
23.
Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, Gazzera C, Veltri A, Sapino A, Papotti M, Freddi M, Palestini N, Sisto G, Novero D: Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom 2015;88:320-329.
24.
Meis-Kindblom JM, Stenman G, Kindblom LG: Differential diagnosis of small round cell tumors. Semin Diagn Pathol 1996;13:213-241.
25.
Bynum JP, Duffield A, Ali SZ: Impact of flow cytometry in liver cytopathology. Acta Cytol 2015;59:51-60.
26.
Acosta M, Pereira J, Arroz M: Screening of carcinoma metastasis by flow cytometry: a study of 238 cases. Cytometry B Clin Cytom 2016;90:289-294.
27.
Hudnall SD, Betancourt E, Barnhart E, Patel J: Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia. Cytometry B Clin Cytom 2008;74:1-8.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.